Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer

Anticancer Research

Volumn 17, Issue 2B, 1997, Pages 1417-1424

  Eissa, Sanaa ^a   Khalifa, A ^a   El Gharib, Amina ^a   Salah, Nevien ^a   Mohamed, M K ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Breast cancer; Epidermal growth factor receptors; Flow cytometry; HER 2 neu; Oncogenes; Prognostic factor; Tumor suppressor genes

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN P53; STEROID RECEPTOR;

ADULT; ANEUPLOIDY; ARTICLE; BREAST CANCER; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MULTIVARIATE ANALYSIS; ONCOGENE C ERB; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLOIDIES; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030894317     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Muir C, Waterhouse J, Mack T: Cancer incidence in five continents. International agency for research on cancer. Lyon 5, 1987.
2. El-Balkainy M: General pathology of cancer. In: General pathology of cancer (El-Balkainy, ed). Cairo, Al-Sadekaa Graphics Center (AGC), 1991.
3. Slamon D, Godolphin W, Jones L, Holt J, Wong S, Keith D, Levin W, Stuart S, Udove J, Ullrich A, Press M: Studies of the Her-2/neu protooncogene in human breast ovarian cancer. Science 244: 707-712, 1989.
4. Contesso G, Omar S, Ibrahim A, et al: Prospective inter-comparative study of breast cancer between Egypt and France. Egypt J Oncol 2: 55-63, 1982.
5. El-Ghazawy IH: A comparative prospective clinicopathological study of breast cancer in Egyptian and French females. Ph D thesis, Ain Shams Faculty of Medicine, Cairo, Egypt, 1987.
6. Richards M, Coleman R, Hamza K et al: Advanced breast cancer in Egyptian women, clinical features and response to endocrine therapy. The Anglo-Egyptian health agreement collaborative study. Eur J Surg Oncol 18: 219-223, 1992.
7. 0) breast carcinoma. J Clin Oncol 7: 355-366. 1989.
8. Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer: a study of 1409 cases of which 359 have been followed 15 years. Br J Cancer 11: 359-377, 1957.
9. Pertschuk L, Kim DS, Nayel K, Feldman JG, Eisenberg KB, Carter AC, Rong ZT, Thelmo WL, Fleisher J, Greene GL: Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer (Phila.) 66: 1663-1670, 1990.